Abstract
Radiologists have long played a key role in the diagnosis and management of children with suspected skeletal dysplasia. Advancing molecular sciences, including the emergence of next generation sequencing and the development of modern rapid drug pipelines have the potential to transform this role.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Mortier GR, Cohn DH, Cormier-Daire V et al (2019) Nosology and classification of genetic skeletal disorders: 2019 revision. Am J Med Genet A 179:2393–2419
Offiah AC, Hall CM (2019) The radiologic diagnosis of skeletal dysplasias: past, present and future. Pediatr Radiol. https://doi.org/10.1007/s00247-019-04533-y
Calder AD, Gaunt T, Hickson M et al (2019) Major skull manifestations of skeletal dysplasias — pictorial essay. Pediatr Radiol. https://doi.org/10.1007/s00247-019-04473-7
Sarioglu FC, Sarioglu O, Guleryuz H (2020) Neuroimaging and calvarial findings in achondroplasia. Pediatr Radiol. https://doi.org/10.1007/s00247-020-04841-8
Schirwani S, Campbell J (2020) Genetics for paediatric radiologists. Pediatr Radiol. https://doi.org/10.1007/s00247-020-04837-4
Whyte MP, Madson KL, Phillips D et al (2016) Asfotase alfa therapy for children with hypophosphatasia. JCI Insight 1:e85971
Breinholt VM, Rasmussen CE, Mygind PH et al (2019) TransCon CNP, a sustained-release C-type natriuretic peptide prodrug, a potentially safe and efficacious new therapeutic modality for the treatment of comorbidities associated with fibroblast growth factor receptor 3-related skeletal dysplasias. J Pharmacol Exp Ther 370:459–471
Garcia S, Dirat B, Tognacci T et al (2013) Postnatal soluble FGFR3 therapy rescues achondroplasia symptoms and restores bone growth in mice. Sci Transl Med 5:203ra124
Komla-Ebri D, Dambroise E, Kramer I et al (2016) Tyrosine kinase inhibitor NVP-BGJ398 functionally improves FGFR3-related dwarfism in mouse model. J Clin Invest 126:1871–1884
Mullan LA, Mularczyk EJ, Kung LH et al (2017) Increased intracellular proteolysis reduces disease severity in an ER stress-associated dwarfism. J Clin Invest 127:3861–3865
Posey KL, Hecht JT (2017) Novel therapeutic interventions for pseudoachondroplasia. Bone 102:60–68
Inubushi T, Lemire I, Irie F, Yamaguchi Y (2018) Palovarotene inhibits osteochondroma formation in a mouse model of multiple hereditary exostoses. J Bone Miner Res 33:658–666
Chakkalakal SA, Uchibe K, Convente MR et al (2016) Palovarotene inhibits heterotopic ossification and maintains limb mobility and growth in mice with the human ACVR1(R206H) fibrodysplasia ossificans progressiva (FOP) mutation. J Bone Miner Res 31:1666–1675
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
Dr. Irving has consultancy agreements with Biomarin, QED Therapeutics, Pfizer/Therachon and Ascendis. There are no further conflicts of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Calder, A.D., Irving, M. Pediatric radiology in the diagnosis and management of skeletal dysplasias — welcome to the era of genomic medicine and modern drug pipelines. Pediatr Radiol 50, 1648–1649 (2020). https://doi.org/10.1007/s00247-020-04858-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00247-020-04858-z